vs
Side-by-side financial comparison of Quest Diagnostics (DGX) and TELUS CORP (TU). Click either name above to swap in a different company.
TELUS CORP is the larger business by last-quarter revenue ($3.7B vs $2.9B, roughly 1.3× Quest Diagnostics). Quest Diagnostics runs the higher net margin — 9.7% vs -4.8%, a 14.5% gap on every dollar of revenue. On growth, Quest Diagnostics posted the faster year-over-year revenue change (9.2% vs 2.2%).
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
TELUS CORPTUEarnings & Financial Report
Telus Corporation is a Canadian publicly traded holding company and conglomerate, headquartered in Vancouver, British Columbia, which is the parent company of several subsidiaries: Telus Communications offers telephony, television, data and Internet services; Telus Mobility offers wireless services; Telus Health operates companies that provide health products and services; and Telus Digital operates worldwide, providing multilingual customer service outsourcing and digital IT services. Telus ...
DGX vs TU — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.9B | $3.7B |
| Net Profit | $281.0M | $-178.8M |
| Gross Margin | — | 90.2% |
| Operating Margin | 15.4% | 3.4% |
| Net Margin | 9.7% | -4.8% |
| Revenue YoY | 9.2% | 2.2% |
| Net Profit YoY | 12.0% | -210.9% |
| EPS (diluted) | $2.24 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.9B | — | ||
| Q4 25 | $2.8B | — | ||
| Q3 25 | $2.8B | — | ||
| Q2 25 | $2.8B | $3.7B | ||
| Q1 25 | $2.7B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.5B | — | ||
| Q2 24 | $2.4B | $3.6B |
| Q1 26 | $281.0M | — | ||
| Q4 25 | $245.0M | — | ||
| Q3 25 | $245.0M | — | ||
| Q2 25 | $282.0M | $-178.8M | ||
| Q1 25 | $220.0M | — | ||
| Q4 24 | $222.0M | — | ||
| Q3 24 | $226.0M | — | ||
| Q2 24 | $229.0M | $161.3M |
| Q1 26 | — | — | ||
| Q4 25 | 32.4% | — | ||
| Q3 25 | 33.7% | — | ||
| Q2 25 | 34.2% | 90.2% | ||
| Q1 25 | 32.5% | — | ||
| Q4 24 | 32.7% | — | ||
| Q3 24 | 32.6% | — | ||
| Q2 24 | 33.5% | 87.9% |
| Q1 26 | 15.4% | — | ||
| Q4 25 | 13.8% | — | ||
| Q3 25 | 13.7% | — | ||
| Q2 25 | 15.9% | 3.4% | ||
| Q1 25 | 13.0% | — | ||
| Q4 24 | 13.8% | — | ||
| Q3 24 | 13.3% | — | ||
| Q2 24 | 14.8% | 13.7% |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 8.7% | — | ||
| Q3 25 | 8.7% | — | ||
| Q2 25 | 10.2% | -4.8% | ||
| Q1 25 | 8.3% | — | ||
| Q4 24 | 8.5% | — | ||
| Q3 24 | 9.1% | — | ||
| Q2 24 | 9.6% | 4.4% |
| Q1 26 | $2.24 | — | ||
| Q4 25 | $2.18 | — | ||
| Q3 25 | $2.16 | — | ||
| Q2 25 | $2.47 | — | ||
| Q1 25 | $1.94 | — | ||
| Q4 24 | $1.95 | — | ||
| Q3 24 | $1.99 | — | ||
| Q2 24 | $2.03 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $393.0M | $2.7B |
| Total DebtLower is stronger | $5.7B | — |
| Stockholders' EquityBook value | $7.7B | $11.8B |
| Total Assets | $16.7B | $44.3B |
| Debt / EquityLower = less leverage | 0.74× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $393.0M | — | ||
| Q4 25 | $420.0M | — | ||
| Q3 25 | $432.0M | — | ||
| Q2 25 | $319.0M | $2.7B | ||
| Q1 25 | $188.0M | — | ||
| Q4 24 | $549.0M | — | ||
| Q3 24 | $764.0M | — | ||
| Q2 24 | $271.0M | $676.7M |
| Q1 26 | $5.7B | — | ||
| Q4 25 | $5.2B | — | ||
| Q3 25 | $5.2B | — | ||
| Q2 25 | $5.2B | — | ||
| Q1 25 | $5.9B | — | ||
| Q4 24 | $5.6B | — | ||
| Q3 24 | $5.6B | — | ||
| Q2 24 | $3.8B | — |
| Q1 26 | $7.7B | — | ||
| Q4 25 | $7.2B | — | ||
| Q3 25 | $7.3B | — | ||
| Q2 25 | $7.2B | $11.8B | ||
| Q1 25 | $6.9B | — | ||
| Q4 24 | $6.8B | — | ||
| Q3 24 | $6.8B | — | ||
| Q2 24 | $6.6B | $12.4B |
| Q1 26 | $16.7B | — | ||
| Q4 25 | $16.2B | — | ||
| Q3 25 | $16.2B | — | ||
| Q2 25 | $16.0B | $44.3B | ||
| Q1 25 | $15.8B | — | ||
| Q4 24 | $16.2B | — | ||
| Q3 24 | $16.1B | — | ||
| Q2 24 | $13.9B | $41.8B |
| Q1 26 | 0.74× | — | ||
| Q4 25 | 0.72× | — | ||
| Q3 25 | 0.71× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 0.85× | — | ||
| Q4 24 | 0.83× | — | ||
| Q3 24 | 0.83× | — | ||
| Q2 24 | 0.58× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $278.0M | $851.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 3.9% | — |
| Cash ConversionOCF / Net Profit | 0.99× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $278.0M | — | ||
| Q4 25 | $465.0M | — | ||
| Q3 25 | $563.0M | — | ||
| Q2 25 | $544.0M | $851.2M | ||
| Q1 25 | $314.0M | — | ||
| Q4 24 | $464.0M | — | ||
| Q3 24 | $356.0M | — | ||
| Q2 24 | $360.0M | $1.0B |
| Q1 26 | — | — | ||
| Q4 25 | $307.0M | — | ||
| Q3 25 | $419.0M | — | ||
| Q2 25 | $436.0M | — | ||
| Q1 25 | $197.0M | — | ||
| Q4 24 | $341.0M | — | ||
| Q3 24 | $250.0M | — | ||
| Q2 24 | $268.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | 10.9% | — | ||
| Q3 25 | 14.9% | — | ||
| Q2 25 | 15.8% | — | ||
| Q1 25 | 7.4% | — | ||
| Q4 24 | 13.0% | — | ||
| Q3 24 | 10.0% | — | ||
| Q2 24 | 11.2% | — |
| Q1 26 | 3.9% | — | ||
| Q4 25 | 5.6% | — | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | 3.9% | — | ||
| Q1 25 | 4.4% | — | ||
| Q4 24 | 4.7% | — | ||
| Q3 24 | 4.3% | — | ||
| Q2 24 | 3.8% | — |
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.90× | — | ||
| Q3 25 | 2.30× | — | ||
| Q2 25 | 1.93× | — | ||
| Q1 25 | 1.43× | — | ||
| Q4 24 | 2.09× | — | ||
| Q3 24 | 1.58× | — | ||
| Q2 24 | 1.57× | 6.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
